Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cleft Palate | 7 | 2023 | 78 | 3.400 |
Why?
|
Cleft Lip | 4 | 2022 | 40 | 1.890 |
Why?
|
Velopharyngeal Insufficiency | 3 | 2023 | 19 | 1.760 |
Why?
|
Abnormalities, Multiple | 3 | 2018 | 167 | 1.680 |
Why?
|
Wound Healing | 2 | 2024 | 205 | 1.280 |
Why?
|
Surgical Flaps | 3 | 2023 | 120 | 1.250 |
Why?
|
Myringoplasty | 1 | 2024 | 6 | 0.960 |
Why?
|
Tympanic Membrane Perforation | 1 | 2024 | 21 | 0.940 |
Why?
|
Bites and Stings | 1 | 2024 | 22 | 0.930 |
Why?
|
Cryopreservation | 1 | 2024 | 31 | 0.930 |
Why?
|
Facial Injuries | 1 | 2024 | 26 | 0.920 |
Why?
|
Pharynx | 3 | 2023 | 33 | 0.840 |
Why?
|
Reoperation | 2 | 2023 | 454 | 0.820 |
Why?
|
Pierre Robin Syndrome | 2 | 2021 | 6 | 0.810 |
Why?
|
Eustachian Tube | 1 | 2021 | 14 | 0.750 |
Why?
|
Lip | 2 | 2021 | 11 | 0.670 |
Why?
|
Uvula | 2 | 2023 | 14 | 0.660 |
Why?
|
Facial Bones | 1 | 2018 | 18 | 0.640 |
Why?
|
Craniofacial Abnormalities | 1 | 2018 | 27 | 0.630 |
Why?
|
Child | 13 | 2024 | 6851 | 0.620 |
Why?
|
Face | 1 | 2018 | 60 | 0.620 |
Why?
|
Cysts | 1 | 2018 | 51 | 0.600 |
Why?
|
Treatment Outcome | 10 | 2024 | 5155 | 0.590 |
Why?
|
Tongue | 2 | 2018 | 39 | 0.570 |
Why?
|
Child, Preschool | 9 | 2024 | 3883 | 0.550 |
Why?
|
Quality of Life | 3 | 2018 | 839 | 0.490 |
Why?
|
Skin Ulcer | 1 | 2014 | 9 | 0.480 |
Why?
|
Alginates | 1 | 2014 | 9 | 0.480 |
Why?
|
Endoscopy | 2 | 2019 | 124 | 0.480 |
Why?
|
Polysaccharides | 1 | 2014 | 51 | 0.470 |
Why?
|
Silver | 1 | 2014 | 47 | 0.460 |
Why?
|
Tympanoplasty | 2 | 2014 | 58 | 0.460 |
Why?
|
Tracheostomy | 1 | 2014 | 71 | 0.450 |
Why?
|
Palate | 1 | 2013 | 12 | 0.430 |
Why?
|
Retrospective Studies | 8 | 2024 | 6134 | 0.430 |
Why?
|
Female | 16 | 2024 | 26635 | 0.430 |
Why?
|
Infant | 8 | 2020 | 3563 | 0.430 |
Why?
|
Larynx | 1 | 2013 | 30 | 0.430 |
Why?
|
Humans | 24 | 2024 | 50208 | 0.420 |
Why?
|
Patient Care Team | 1 | 2014 | 257 | 0.420 |
Why?
|
Cerebral Palsy | 1 | 2013 | 40 | 0.420 |
Why?
|
Postoperative Complications | 3 | 2023 | 996 | 0.420 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2013 | 67 | 0.400 |
Why?
|
Male | 15 | 2024 | 25399 | 0.390 |
Why?
|
Hemangioma | 1 | 2012 | 83 | 0.380 |
Why?
|
Otitis Media with Effusion | 1 | 2010 | 15 | 0.370 |
Why?
|
Laryngeal Diseases | 1 | 2010 | 12 | 0.350 |
Why?
|
Tracheal Diseases | 1 | 2010 | 12 | 0.350 |
Why?
|
Infant, Newborn | 5 | 2018 | 2766 | 0.350 |
Why?
|
Trachea | 1 | 2010 | 52 | 0.330 |
Why?
|
Hearing Loss | 1 | 2010 | 90 | 0.330 |
Why?
|
Arteriovenous Malformations | 1 | 2009 | 66 | 0.310 |
Why?
|
Cerebellopontine Angle | 1 | 2008 | 6 | 0.310 |
Why?
|
Succinate Dehydrogenase | 1 | 2008 | 23 | 0.300 |
Why?
|
Cerebellar Neoplasms | 1 | 2008 | 22 | 0.300 |
Why?
|
Paraganglioma | 1 | 2008 | 14 | 0.300 |
Why?
|
Neuroma, Acoustic | 1 | 2008 | 20 | 0.300 |
Why?
|
Adolescent | 7 | 2024 | 6390 | 0.300 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2008 | 44 | 0.300 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 176 | 0.290 |
Why?
|
Follow-Up Studies | 3 | 2018 | 2190 | 0.250 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 509 | 0.240 |
Why?
|
Dogs | 1 | 2024 | 185 | 0.230 |
Why?
|
Umbilical Cord | 1 | 2024 | 35 | 0.230 |
Why?
|
Clinical Clerkship | 1 | 2023 | 30 | 0.220 |
Why?
|
Laryngoscopy | 3 | 2014 | 58 | 0.210 |
Why?
|
Risk Assessment | 3 | 2018 | 1262 | 0.200 |
Why?
|
Students, Medical | 1 | 2023 | 155 | 0.190 |
Why?
|
Air Microbiology | 1 | 2020 | 12 | 0.190 |
Why?
|
Adenoidectomy | 1 | 2020 | 35 | 0.180 |
Why?
|
Osteogenesis, Distraction | 1 | 2021 | 78 | 0.180 |
Why?
|
Bronchoscopy | 2 | 2012 | 70 | 0.180 |
Why?
|
Tonsillectomy | 1 | 2020 | 49 | 0.180 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2020 | 46 | 0.180 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 76 | 0.170 |
Why?
|
Surgical Wound Infection | 1 | 2020 | 116 | 0.170 |
Why?
|
Audiovisual Aids | 1 | 2019 | 12 | 0.170 |
Why?
|
Goldenhar Syndrome | 1 | 2018 | 3 | 0.160 |
Why?
|
Dental Pulp Cavity | 1 | 2018 | 6 | 0.160 |
Why?
|
Tooth Abnormalities | 1 | 2018 | 12 | 0.160 |
Why?
|
Video Recording | 1 | 2019 | 80 | 0.160 |
Why?
|
Interferon Regulatory Factors | 1 | 2018 | 17 | 0.160 |
Why?
|
Otolaryngology | 1 | 2019 | 56 | 0.160 |
Why?
|
Rhinitis | 1 | 2018 | 29 | 0.150 |
Why?
|
Sinusitis | 1 | 2018 | 50 | 0.150 |
Why?
|
Head | 2 | 2022 | 73 | 0.130 |
Why?
|
Pilot Projects | 2 | 2014 | 697 | 0.120 |
Why?
|
Bandages, Hydrocolloid | 1 | 2014 | 4 | 0.120 |
Why?
|
Gels | 1 | 2014 | 21 | 0.120 |
Why?
|
Interdisciplinary Communication | 1 | 2014 | 55 | 0.120 |
Why?
|
Cartilage | 1 | 2014 | 48 | 0.120 |
Why?
|
Laryngomalacia | 1 | 2014 | 24 | 0.110 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 247 | 0.110 |
Why?
|
Disease Management | 1 | 2014 | 176 | 0.110 |
Why?
|
Hospitals, University | 1 | 2013 | 77 | 0.110 |
Why?
|
Polysomnography | 1 | 2013 | 71 | 0.110 |
Why?
|
Child Development | 1 | 2014 | 191 | 0.100 |
Why?
|
Lumbosacral Region | 1 | 2012 | 12 | 0.100 |
Why?
|
Lasers, Dye | 1 | 2012 | 9 | 0.100 |
Why?
|
Watchful Waiting | 1 | 2012 | 27 | 0.100 |
Why?
|
Off-Label Use | 1 | 2012 | 25 | 0.100 |
Why?
|
Interferon-alpha | 1 | 2012 | 48 | 0.100 |
Why?
|
Vincristine | 1 | 2012 | 88 | 0.100 |
Why?
|
Propranolol | 1 | 2012 | 78 | 0.100 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 70 | 0.100 |
Why?
|
Animals | 2 | 2024 | 13246 | 0.100 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 449 | 0.100 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2012 | 105 | 0.100 |
Why?
|
Congenital Abnormalities | 1 | 2012 | 112 | 0.090 |
Why?
|
Risk Factors | 2 | 2020 | 3629 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2012 | 487 | 0.090 |
Why?
|
Antiviral Agents | 1 | 2012 | 173 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 1043 | 0.090 |
Why?
|
Fiber Optic Technology | 1 | 2010 | 16 | 0.090 |
Why?
|
Glucocorticoids | 1 | 2012 | 226 | 0.090 |
Why?
|
Decision Making | 1 | 2012 | 267 | 0.090 |
Why?
|
Safety | 1 | 2010 | 77 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 1161 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2012 | 273 | 0.080 |
Why?
|
Recurrence | 1 | 2010 | 662 | 0.080 |
Why?
|
Neck | 1 | 2009 | 100 | 0.080 |
Why?
|
Young Adult | 3 | 2018 | 3981 | 0.080 |
Why?
|
Curriculum | 2 | 2023 | 400 | 0.080 |
Why?
|
Clinical Competence | 2 | 2023 | 392 | 0.080 |
Why?
|
Chronic Disease | 1 | 2010 | 571 | 0.080 |
Why?
|
Proline | 1 | 2008 | 30 | 0.080 |
Why?
|
Codon | 1 | 2008 | 47 | 0.080 |
Why?
|
Amino Acid Substitution | 1 | 2008 | 82 | 0.080 |
Why?
|
Prospective Studies | 3 | 2020 | 2379 | 0.070 |
Why?
|
Age Factors | 1 | 2010 | 1092 | 0.070 |
Why?
|
Leucine | 1 | 2008 | 117 | 0.070 |
Why?
|
Alleles | 1 | 2008 | 251 | 0.070 |
Why?
|
Chromosome Deletion | 1 | 2008 | 140 | 0.070 |
Why?
|
Base Sequence | 1 | 2008 | 644 | 0.070 |
Why?
|
Radiography | 1 | 2008 | 491 | 0.070 |
Why?
|
Genotype | 1 | 2008 | 534 | 0.070 |
Why?
|
Radiosurgery | 1 | 2008 | 118 | 0.070 |
Why?
|
Time Factors | 1 | 2010 | 2922 | 0.060 |
Why?
|
Sutures | 1 | 2023 | 40 | 0.060 |
Why?
|
Personal Satisfaction | 1 | 2022 | 75 | 0.050 |
Why?
|
Gills | 1 | 2021 | 6 | 0.050 |
Why?
|
Nasopharynx | 1 | 2020 | 25 | 0.050 |
Why?
|
Risk | 1 | 2020 | 324 | 0.040 |
Why?
|
Radiography, Dental | 1 | 2018 | 5 | 0.040 |
Why?
|
Radiography, Panoramic | 1 | 2018 | 9 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2020 | 688 | 0.040 |
Why?
|
Nasal Polyps | 1 | 2018 | 6 | 0.040 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2018 | 35 | 0.040 |
Why?
|
Syndrome | 1 | 2018 | 238 | 0.040 |
Why?
|
Algorithms | 1 | 2021 | 618 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 1554 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 1422 | 0.030 |
Why?
|
Phenotype | 1 | 2018 | 733 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2019 | 1185 | 0.030 |
Why?
|
Transcription Factors | 1 | 2018 | 564 | 0.030 |
Why?
|
Hearing Tests | 1 | 2014 | 23 | 0.030 |
Why?
|
Hearing | 1 | 2014 | 59 | 0.030 |
Why?
|
Sickness Impact Profile | 1 | 2014 | 28 | 0.030 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2014 | 34 | 0.030 |
Why?
|
Glottis | 1 | 2014 | 32 | 0.030 |
Why?
|
Adult | 1 | 2009 | 13324 | 0.030 |
Why?
|
United States | 1 | 2023 | 4874 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2014 | 564 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2014 | 951 | 0.020 |
Why?
|